Hepatitis C viral infection after liver transplantation
Elizabeth C. Verna, Robert S. Brown – 23 July 2012 – Watch the interview with the authors
Hepatitis C viral infection in patients with chronic kidney disease
Andres F. Carrion, Paul Martin – 23 July 2012 – Watch the interview with the authors
Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: A systematic review and meta‐analysis
Rania Rabie, Khalid Mumtaz, Eberhard L. Renner – 23 July 2012 – Cyclosporine A (CSA), but not tacrolimus (TAC), inhibits hepatitis C virus (HCV) replication in vitro. Clinical reports on the efficacy of interferon‐α (IFNα)–based antiviral therapy (AVT) for recurrent HCV after liver transplantation (LT) with CSA and TAC are conflicting. Our aim was to assess whether AVT for recurrent HCV after LT is more effective with CSA or TAC. We performed an electronic database search (1995‐2012) and a manual abstract search (2005‐2012).
Liver transplantation in septuagenarians receiving model for end‐stage liver disease exception points for hepatocellular carcinoma: The national experience
Jason Schwartz, Heather Thiesset, Terry Box, William Hutson, John Sorensen – 23 July 2012
MicroRNA‐221 overexpression accelerates hepatocyte proliferation during liver regeneration
Qinggong Yuan, Komal Loya, Bhavna Rani, Selina Möbus, Asha Balakrishnan, Jutta Lamle, Toni Cathomen, Arndt Vogel, Michael P. Manns, Michael Ott, Tobias Cantz, Amar Deep Sharma – 23 July 2012 – The tightly controlled replication of hepatocytes in liver regeneration and uncontrolled proliferation of tumor cells in hepatocellular carcinoma (HCC) are often modulated by common regulatory pathways. Several microRNAs (miRNAs) are involved in HCC progression by modulating posttranscriptional expression of multiple target genes.
Hepatitis C viral infection in drug users
Diana L. Sylvestre – 23 July 2012 – Watch an interview with the author
Hepatitis C viral infection in difficult‐to‐treat populations: An overview
Nezam H. Afdhal – 23 July 2012 – Watch a video presentation of this article
Hepatitis C genotype 1 infection in HIV–Infected patients in the era of direct‐acting antiviral therapy
Mark S. Sulkowski – 23 July 2012 – Watch the interview with the author
Hepatitis C viral infection in patients with hemophilia and hemolytic disorders
Eric S. Orman, Michael W. Fried – 23 July 2012 – Watch the interview with the authors
Long‐term quality of life of donors after living donor liver transplantation
Yasutsugu Takada, Yoshimi Suzukamo, Fumitaka Oike, Hiroto Egawa, Satoshi Morita, Shunichi Fukuhara, Shinji Uemoto, Koichi Tanaka – 20 July 2012 – The aims of this study were to investigate the long‐term effects of living donor liver transplantation (LDLT) on the health‐related quality of life (HRQOL) of donors with the Short Form 36 health survey and to determine the risk factors for poor outcomes. Between June 1990 and June 2004, LDLT was performed 1000 times at Kyoto University Hospital.